Correlation Between Protagenic Therapeutics and XOMA

Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagenic Therapeutics and XOMA Corporation, you can compare the effects of market volatilities on Protagenic Therapeutics and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and XOMA.

Diversification Opportunities for Protagenic Therapeutics and XOMA

-0.53

Correlation Coefficient

Protagenic Therapeutics  XOMA

Excellent diversification

The 3 months correlation between Protagenic and XOMA is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and XOMA go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and XOMA

Given the investment horizon of 90 days Protagenic Therapeutics is expected to under-perform the XOMA. In addition to that, Protagenic Therapeutics is 23.9 times more volatile than XOMA Corporation. It trades about -0.02 of its total potential returns per unit of risk. XOMA Corporation is currently generating about 0.12 per unit of volatility. If you would invest  2,469  in XOMA Corporation on September 13, 2024 and sell it today you would earn a total of  71.00  from holding XOMA Corporation or generate 2.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Protagenic Therapeutics  vs.  XOMA Corp.

Protagenic Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

XOMA

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Protagenic Therapeutics and XOMA

The main advantage of trading using opposite Protagenic Therapeutics and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.

The idea behind Protagenic Therapeutics and XOMA Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.